Sa. Thomas et al., QUANTIFICATION OF EFFLUX INTO THE BLOOD AND BRAIN OF INTRAVENTRICULARLY PERFUSED [H-3] THYMIDINE IN THE ANESTHETIZED RABBIT, Experimental physiology, 82(1), 1997, pp. 139-148
Studies using choroid plexuses incubated in vitro have led to the conc
lusion that pyrimidine deoxyribonucleosides, such as thymidine, enter
the brain predominantly through the blood-cerebrospinal fluid (CSF) ba
rrier across the choroid plexuses. In order to examine this hypothesis
, ventriculocisternal perfusions were carried out to determine the mag
nitude of the passage of [H-3]thymidine from the CSF into the brain an
d blood. These experiments demonstrated that approximately 50 % of the
[H-3]thymidine was eliminated from the CSF perfusate, some 41.6 +/- 5
.6 % passing into the blood and only 7.6 +/- 0.6 % to the brain. Efflu
x into both the blood and brain was saturable, with a K-m of 17.8 mu M
and a V-max of 0.47 nM min(-1), and partially nitrobenzylthioinosine
(NBMPR) sensitive. However, a non-saturable component did exist (K-d,
13.8 mu l min(-1)). Overall, the rapid removal of [H-3]thymidine from
the CSF and its low uptake from the CSF into the brain suggests that t
he choroid plexuses would be an inefficient pathway for the entry of t
his pyrimidine deoxyribonucleoside into the brain.